[Federal Register Volume 72, Number 118 (Wednesday, June 20, 2007)]
[Notices]
[Pages 34040-34041]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-11916]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated November 21, 2006, and published in the Federal 
Register on December 1, 2006, (71 FR 69593), Noramco Inc., 1440 Olympic 
Drive, Athens, Georgia 30601, made application by letter to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Oxymorphone (9652), a basic class of controlled 
substance listed in schedule II.

[[Page 34041]]

    The company plans to manufacture for in-house dosage form 
production and for sales to other dosage form manufacturers.
    When the company first submitted their application, the company 
submitted information to DEA that the firm would be manufacturing 
Oxymorphone for in-house dosage form production and sales to other 
dosage form manufacturers. Upon further investigation by the DEA it was 
uncovered that the company would only be producing bulk material for 
dosage form manufacturers. DEA will grant this registration for the 
production of bulk manufacturing of Oxymorphone.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Noramco Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Noramco Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic class of controlled substance listed.

    Dated: June 7, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-11916 Filed 6-19-07; 8:45 am]
BILLING CODE 4410-09-P